Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
doi: 10.21037/apm.2019.10.01 2
The hidden cost of quitting The most expensive outcome is starting tirzepatide at a standard dose, experiencing intolerable side effects, and quitting after two to four weeks
The METAOD006 (OPTIONS) oral Phase 2b trial measured weight at 12 and 24 weeks
PlexusDx Tirzepatide Injection Protocol runs $3,468/year at $289/mo month-to-month (or $2,988/year at $249/mo on the 6-month plan), and the Tirzepatide Oral Protocol runs $4,188/year at $349/mo (or $3,348/year at $279/mo on the 6-month plan)
US$ 23.24
:max_bytes(150000):strip_icc()/Health-GettyImages-1413029048-1570d2105e4840479118ceddf6c46e19.jpg)
US$ 24.16
US$ 22.94
US$ 24.00
US$ 24.48
US$ 24.07
US$ 28.17
